Advances in the monitoring of oral anticoagulation: Point-of-care testing, patient self-monitoring, and patient self-management

Journal of Thrombosis and Thrombolysis

Volumn 3, Issue 4, 1996, Pages 377-383

  Leaning, Katharine E ^a   Ansell, Jack E ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Oral anticoagulation; Point of care testing; Prothrombin time; Self management; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ACCURACY; ARTICLE; BLOOD CLOTTING DISORDER; HOME MONITORING; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROTHROMBIN TIME; SAFETY; SELF CARE;

EID: 0029833457     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00133081     Document Type: Article

References (29)

1. Ansell J. Oral anticoagulant therapy: Fifty years later. Arch Intern Med 1993;153:586-596.
2. Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991;151:1950-1953.
3. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-281.
4. Agency for Health Care Policy Research. Life-saving treatments to prevent stroke underused. Press release, September 7, 1995.
5. Garabedian-Ruffalo SM, Gray DR, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-308.
6. Cortelazzo S, Finazzi G, Verio P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993;69: 316-320.
7. Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995;15:732-739.
8. Bussey HL, Chiquette E, Amato MG. Anticoagulation clinic care versus routine medical care: A review and interim report. J Thromb Thrombolys 1996;2:315-319.
9. Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technic for measuring the prothrombin time. Am J Clin Pathol 1987;88:442-446.
10. Yano Y, Kambayashi J, Murata K, et al. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Res 1992;66:583-590.
11. Weibert RT, Adler DS. Evaluation of a capillary whole blood prothrombin time measurement system. Clin Pharm 1989;8:864-867.
12. Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 1991;44:950-953.
13. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992;152:589-592.
14. Tripodi A, Arbini AA, Chantarangkul V, et al. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio? Thrombo Hemosta 1993;70:921-924.
15. Oberhardt BJ, Dermott SC, Taylor M, Alkadi ZY, Abruzzini AF, Gresalfi NJ. Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin Chem 1991;37:520-526.
16. Rose VL, Dermott SC, Murray BF, et al. Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer. Arch Pathol Lab Med 1993;117:611-617.
17. Fabbrini N, Messmore H, Balbale S, et al. Pilot study to determine use of a TAS analyzer in an anticoagulation clinic setting. Blood 1995;86(Suppl 1):869a.
18. Tripodi A, Clerici M, Negri B, Chantarangkul V, Mannucci PM. International sensitivity index determination for a new, very sensitive point-of-care testing device to monitor oral anticoagulant therapy. Assessment of adequacy to the recommended WHO model. Blood 1995;86(Suppl 1):890a.
19. Kaatz AA, White RH, Hill J, et al. Accuracy of laboratory and portable monitor International Normalized Ratio determinations. Arch Intern Med 1995;155:1861-1867.
20. Ansell J, Becker D, Andrew M, Becker R, Triplett D, Cimini C, LaDuca F. Accurate and precise prothrombin time measurement in a multicenter anticoagulation trial employing patient self-testing. Blood 1995;86(Suppl 1):864a.
21. Andrew M, Marzinotto V, Adams M, Cimini C, Triplett D, LaDuca F. Monitoring of oral anticoagulant therapy in pediatric patients using a new microsample PT device. Blood 1995:86(Suppl 1):863a.
22. Belsey RE, Fischer PM, Baer DM. An evaluation of a whole blood prothrombin analyzer designed for use by individuals without formal laboratory training. J Fam Pract 1991;33: 266-271.
23. White RH, McCurdy, SA, von Marensdorff H, Woodruff DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med 1989;111: 730-737.
24. Anderson D, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993;153:1441-1447.
25. Erdman S, Vidne B, Levy MJ. A self-control method for long-term anticoagulation therapy. J Cardiovasc Surg 1974;15:454-457.
26. Schachner A, Deviri E, Shabat S. In: Butchart EG, Bodnar E, eds. Patient-regulated anticoagulation. Thrombosis, Embolism, and Bleeding. London: ICR Publishers, 1992: 318-324.
27. Ansell J, Holden A, Knapic N. Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Arch Intern Med 1989;149:2509-2511.
28. Ansell J, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-2189.
29. Bernardo, A. Experience with patient self-management of oral anticoagulation. J Thromb Thrombolys 1996;2:321-325.